Neurocrine Biosciences NBIX
NASDAQ NBIX
$154.21 -1.32 (-0.85%)
At close: Aug 20, 2026 · 12:02 PM UTC

Neurocrine Biosciences (NBIX) Gross Margin Growth (1y) (2018 - 2026)

Neurocrine Biosciences (NBIX) Gross Margin Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Haleon 44.05 Bn 43.08 Bn - -
2 Teva Pharmaceutical Industries 43.39 Bn 39.74 Bn 2.15 Bn 164.00
3 Zoetis 31.86 Bn 30.18 Bn 1.05 Bn -378.00
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn -397.00
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn -173.00
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn 156.00
7 Neurocrine Biosciences 15.58 Bn 15.19 Bn 935.80 Mn -92.00
8 Elanco Animal Health 11.92 Bn 11.39 Bn 798.00 Mn 88.00
9 Dr Reddys Laboratories 10.16 Bn 9.99 Bn - -
10 Alkermes 8.17 Bn 7.51 Bn 397.90 Mn -712.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -92.00
Mar 31, 2026 -9.00
Dec 31, 2025 -70.00
Sep 30, 2025 -48.00
Jun 30, 2025 -8.00
Mar 31, 2025 -15.00
Dec 31, 2024 17.00
Sep 30, 2024 96.00
Jun 30, 2024 98.00
Mar 31, 2024 57.00
Dec 31, 2023 22.00
Sep 30, 2023 -67.00
Jun 30, 2023 2,146.00
Mar 31, 2023 -54.00
Dec 31, 2022 -55.00
Sep 30, 2022 -15.00
Jun 30, 2022 -2,293.00
Mar 31, 2022 -26.00
Dec 31, 2021 -14.00
Sep 30, 2021 -37.00